ESPE Yearbook of Paediatric Endocrinology

Brief summary: The WHO List of Essential Medicines now includes more than 400 medicines. The addition to the list of medicines considered effective, safe, and important for priority public health is made increasingly complicated by the high cost of new drugs. This commentary recommends a new approach whereby consideration would be given separately to economic aspects and to clinical benefits.Every two years, the WHO publishes a revised List of Essential ...

To read the full abstract: J Public Health (Oxf) 2017:1-9Our efforts to control overweight and obesity in children are severely hampered because most of their parents (and indeed most of their health professionals!) cannot visually recognise an obese child, let alone one who is overweight. This is particularly difficult at around the ages 4-6 years old because this coincides with the BMI n...

To read the full abstract: N Engl J Med 2017;377:13-27Other estimates of the global trends and projections in obesity have been published. In this regard, the current analysis provides similar, albeit equally worrying, data on the trends towards more obesity across all regions of the world. Moreover, a particular advance of this current study, which was funded by the Bill and Melind...

To read the full abstract: J Rheumatol. 2018; 45(8): 1173In recent years, biologic agents have clearly been shown to be effective in maintaining remission and improving linear growth in children with inflammatory bowel disease and other chronic inflammatory diseases (1–3). This prospective cohort study analyzed growth in 187 patients (143 females, mean age 11±4 years; including...